Menu

Health Care REIT, Inc. Reports Fourth Quarter and Year End 2008 Results

02/04/2009

Click here for a PDF of the release.

Click here for 4Q08 Supplemental Information.

TOLEDO, Ohio--(BUSINESS WIRE)--Feb. 24, 2009-- Health Care REIT, Inc. (NYSE:HCN) today announced operating results for the company’s fourth quarter and year ended December 31, 2008.

“In one of the toughest years on record for both REITs and the broader equity markets, we generated a positive 0.5% total return for our shareholders in 2008,” commented George L. Chapman, chief executive officer and president of Health Care REIT, Inc. “In addition, we raised over $775 million of opportunistic equity capital and completed in excess of $1.0 billion of net real estate investments, concentrated in combination senior housing properties and high-quality medical facilities. As we enter 2009, we remain focused on preserving liquidity, but we intend to take advantage of what we believe will be increasingly attractive investment opportunities over time.”

Recent Highlights.

  • Achieved 4Q08 normalized FFO of $0.83 per share, up 4%
  • Achieved 4Q08 normalized FAD of $0.77 per share, up 3%
  • Achieved 2008 normalized FFO of $3.38 per share, up 8%
  • Achieved 2008 normalized FAD of $3.16 per share, up 9%
  • Completed 2008 net new investments totaling $1.0 billion
  • Recognized $163.9 million of gains on sales of property, generating $287.0 million in net proceeds
  • Added to the S&P 500 Index in January 2009

Key Performance Indicators.

                        4Q08     4Q07     Change     2008     2007     Change
Net income available to common                                                      
stockholders (NICS) per diluted share                       $0.22     $0.52     -58%     $2.81     $1.46     92%
Normalized FFO per diluted share                       $0.83     $0.80     4%     $3.38     $3.12     8%
Normalized FAD per diluted share                       $0.77     $0.75     3%     $3.16     $2.91     9%
Dividends per common share (1)                       $0.68     $0.66     3%     $2.70     $2.62     3%
Normalized FFO Payout Ratio                       82%     83%           80%     84%      
Normalized FAD Payout Ratio                       88%     88%           85%     90%      
(1)   The $0.3409 prorated dividend paid on December 28, 2006 in connection with the Windrose merger has been included in 2007.
     

4Q08 Earnings. The following table summarizes certain items impacting NICS, FFO and FAD:

  NICS FFO FAD
    4Q08   4Q07   Change   4Q08   4Q07   Change   4Q08   4Q07   Change
Per diluted share   $ 0.22     $ 0.52   -58 %   $ 0.31     $ 0.86   -64 %   $ 0.37     $ 0.89   -58 %
Includes impact of:                                    
Gains on sales of real property (1)   $ 0.32     $ 0.14                            
Additional other income (2)   $ 0.02     $ 0.05       $ 0.02     $ 0.05       $ 0.02     $ 0.05    
Impairment charges (3)     ($0.31 )             ($0.31 )             ($0.31 )        
Realized loss on derivatives (4)     ($0.21 )             ($0.21 )             ($0.21 )        
Terminated transaction costs (5)     ($0.02 )             ($0.02 )             ($0.02 )        
Other items, net (6)   $ 0.00     $ 0.01       $ 0.00     $ 0.01       $ 0.00     $ 0.01    
Prepaid/straight-line rent cash receipts (7)                         $ 0.12     $ 0.08    
Per diluted share - normalized (a)             $ 0.83     $ 0.80   4 %   $ 0.77     $ 0.75   3 %
(a)   Amounts may not sum due to rounding
    (1)   $33,120,000 and $11,662,000 of gains in 4Q08 and 4Q07, respectively.
    (2)   $2,500,000 and $3,900,000 of additional other income in 4Q08 and 4Q07, respectively.
    (3)   $32,648,000 of impairment charges in 4Q08.
    (4)   $21,880,000 of realized loss on derivatives in 4Q08.
    (5)   $2,291,000 of non-recurring terminated transaction costs in 4Q08.
    (6)   See reconciliations for other items.
    (7)   $12,602,000 and $6,678,000 of receipts in 4Q08 and 4Q07, respectively.
         

2008 Year End Earnings. The following table summarizes certain items impacting NICS, FFO and FAD:

  NICS FFO FAD
    2008       2007     Change     2008       2007     Change     2008       2007     Change
Per diluted share $ 2.81     $ 1.46     92 %   $ 2.80     $ 3.16     -11 %   $ 2.87     $ 3.18     -10 %
Includes impact of:                                  
Gains on sales of real property (1) $ 1.74     $ 0.18                              
Additional other income (2) $ 0.03     $ 0.05         $ 0.03     $ 0.05         $ 0.03     $ 0.05      
Impairment charges (3)   ($0.35 )             ($0.35 )             ($0.35 )        
Realized loss on derivatives (4)   ($0.25 )             ($0.25 )             ($0.25 )        
Terminated transaction costs (5)   ($0.02 )             ($0.02 )             ($0.02 )        
Other items, net (6) $ 0.01       ($0.01 )       $ 0.01       ($0.01 )       $ 0.01       ($0.01 )    
Cash receipts - prepaid/straight-line 
 rent (7)
                        $ 0.30     $ 0.22      
Per diluted share - normalized (a)             $ 3.38     $ 3.12     8 %   $ 3.16     $ 2.91     9 %
(a)   Amounts may not sum due to rounding
    (1)   $163,933,000 and $14,437,000 of gains in 2008 and 2007, respectively.
    (2)   $2,500,000 and $3,900,000 of additional other income in 2008 and 2007, respectively.
    (3)   $32,648,000 of impairment charges in 2008.
    (4)   $23,393,000 of loss on derivatives in 2008.
    (5)   $2,291,000 of non-recurring terminated transaction costs in 2008.
    (6)   See reconciliations for other items.
    (7)   $28,282,000 and $17,469,000 of receipts in 2008 and 2007, respectively.
         

Significant 2008 Items. The following items impacted 2008 earnings:

  • $163.9 million of net gains ($1.74 per diluted share) were recognized in connection with the sales of 38 properties. These sales generated $287.0 million of net proceeds.
  • $2.5 million of additional other income ($0.03 per diluted share) was recognized in connection with a lease termination.
  • $32.6 million of impairment charges ($0.35 per diluted share) were recognized in connection with a portfolio of medical office buildings that the company intends to sell in fiscal 2009. The portfolio includes smaller, low occupancy buildings located generally off campus that are inconsistent with the company’s strategy of owning larger properties affiliated with high quality health systems. These properties have been classified as held-for-sale and historical results have been reclassified to discontinued operations.
  • $23.4 million of realized loss on derivatives ($0.25 per diluted share) was recognized in connection with the termination of two forward-starting interest rate swap agreements. The swaps were put in place in September 2007 and were intended to hedge the 10-year treasury rate component of an anticipated offering of 10-year unsecured notes that did not take place as a result of the severe dislocation in the credit markets.
  • $2.3 million of non-recurring terminated transaction costs ($0.02 per diluted share) primarily related to the termination of the Arcapita/Sunrise agreement.

Dividends for Fourth Quarter 2008. As previously announced, the Board of Directors declared a cash dividend for the quarter ended December 31, 2008 of $0.68 per share, as compared to $0.66 per share for the same period in 2007. The cash dividend was paid on February 20, 2009 and was the company’s 151st consecutive quarterly dividend payment.

Dividends for 2009. The Board of Directors approved a quarterly cash dividend rate of $0.68 per share per quarter ($2.72 per share annually), commencing with the May 2009 dividend. The company’s dividend policy is reviewed annually during the Board of Directors’ January planning session. The declaration and payment of quarterly dividends remains subject to review by and approval of the Board of Directors.

Restatement of Earnings due to Convertible Debt. In May, 2008 the Financial Accounting Standards Board issued FASB Staff Position 14-1 (“FSP”) which provides guidance on accounting for debt that may be settled in cash upon conversion. This applies to the company’s convertible senior unsecured note issuances in November 2006 and July 2007. The FSP is effective for fiscal year 2009 and requires that prior years be restated to reflect this accounting treatment in all applicable prior periods. The following table illustrates the impact of this restatement for the periods presented (amounts in thousands except per share amounts):

          4Q07 4Q08   2007 2008
Additional interest expense:                  
November 2006 issuance         $ 320   $ 320     $ 1,280   $ 1,280  
July 2007 issuance         $ 883   $ 883     $ 1,766   $ 3,532  
Total         $ 1,203   $ 1,203     $ 3,046   $ 4,812  
Fully diluted weighted-average shares           82,784     103,840       79,409     94,309  
Amount per share         $ 0.01   $ 0.01     $ 0.04   $ 0.05  
                   
Summary of per share impacts:                  
Net income available to common
 stockholders:
                 
As reported         $ 0.52   $ 0.22     $ 1.46   $ 2.81  
Convertible debt adjustment         $ (0.01 ) $ (0.01 )   $ (0.04 ) $ (0.05 )
Restated         $ 0.51   $ 0.21     $ 1.42   $ 2.76  
                   
Funds from operations-normalized:                  
As reported         $ 0.80   $ 0.83     $ 3.12   $ 3.38  
Convertible debt adjustment         $ (0.01 ) $ (0.01 )   $ (0.04 ) $ (0.05 )
Restated         $ 0.79   $ 0.82     $ 3.08   $ 3.33  
                                   

Outlook for 2009. The company is introducing its 2009 guidance and expects to report net income available to common stockholders in a range of $1.59 to $1.69 per diluted share; normalized FFO in a range of $3.20 to $3.30 per diluted share; and normalized FAD in a range of $3.08 to $3.18 per diluted share. FFO guidance should be compared to the $3.33 per diluted share actual 2008 results as restated for the convertible debt accounting change. In preparing its guidance, the company made the following significant assumptions:

  • Gross investments comprised of funded new development totaling $600 million with the investment balance capitalized at the company’s average cost of debt (approximately 5.7%) and recorded as a reduction in interest expense until completion. No acquisitions are assumed in the gross investment forecast.
  • Dispositions of $200 to $300 million at average yields of 10% to 11%.
  • Net investments of $300 million to $400 million.
  • Development conversions of approximately $537 million heavily weighted toward the latter half of the year.
  • General and administrative expenses of approximately $46 million for the full year 2009. Our G&A forecast includes $2.9 million of anticipated expensing of accelerated stock-based compensation in 1Q09 but excludes $3.9 million in connection with the departure of Raymond Braun in 1Q09.
  • 5.8 million shares of common stock issued on February 3, 2009 for approximately $211 million in net proceeds in connection with our inclusion in the S&P 500 Index.

The company’s guidance excludes any impairments, unanticipated additions to the loan loss reserve or other additional one-time items, including any additional cash payments other than normal monthly rental payments. Please see the exhibits for a reconciliation of the outlook for net income available to common stockholders to normalized FFO and FAD.

Conference Call Information. The company has scheduled a conference call on Wednesday, February 25, 2009 at 10:00 a.m. Eastern Time to discuss its fourth quarter and year end 2008 results, industry trends, portfolio performance and outlook for 2009. Telephone access will be available by dialing 888-346-2469 or 706-758-4923 (international). For those unable to listen to the call live, a taped rebroadcast will be available beginning two hours after completion of the call through March 4, 2009. To access the rebroadcast, dial 800-642-1687 or 706-645-9291 (international). The conference ID number is 82951201. To participate in the webcast, log on to www.hcreit.com or www.earnings.com 15 minutes before the call to download the necessary software. Replays will be available for 90 days through the same websites. This earnings release is posted on the company’s website under the heading News & Events.

Supplemental Reporting Measures. The company believes that net income available to common stockholders (NICS), as defined by U.S. generally accepted accounting principles (U.S. GAAP), is the most appropriate earnings measurement. However, the company considers funds from operations (FFO) and funds available for distribution (FAD) to be useful supplemental measures of its operating performance. Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the National Association of Real Estate Investment Trusts (NAREIT) created FFO as a supplemental measure of operating performance for REITs that excludes historical cost depreciation from net income. FFO, as defined by NAREIT, means net income, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate, plus real estate depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures. Normalized FFO represents FFO adjusted for unusual and non-recurring items. FAD represents FFO excluding net straight-line rental adjustments, rental income related to above/below market leases and amortization of deferred loan expenses and less cash used to fund capital expenditures, tenant improvements and lease commissions. Normalized FAD represents FAD excluding prepaid/straight-line rent cash receipts and adjusted for unusual and non-recurring items.

The company’s supplemental reporting measures and similarly entitled financial measures are widely used by investors and equity analysts in the valuation, comparison and investment recommendations of companies. The company’s management uses these financial measures to facilitate internal and external comparisons to historical operating results and in making operating decisions. Additionally, they are utilized by the Board of Directors to evaluate management. The supplemental reporting measures do not represent net income or cash flow provided from operating activities as determined in accordance with U.S. GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the supplemental reporting measures, as defined by the company, may not be comparable to similarly entitled items reported by other real estate investment trusts or other companies. Please see the exhibits for reconciliations of the supplemental reporting measures.

About Health Care REIT. Health Care REIT, Inc., an S&P 500 company with headquarters in Toledo, Ohio, is a real estate investment trust that invests across the full spectrum of senior housing and health care real estate. The company also provides an extensive array of property management and development services. As of December 31, 2008, the company’s broadly diversified portfolio consisted of 633 properties in 39 states. More information is available on the Internet at www.hcreit.com.

This document may contain “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements concern and are based upon, among other things, the possible expansion of the company’s portfolio; the sale of properties; the performance of its operators/tenants and properties; its occupancy rates; its ability to acquire, develop and/or manage properties; its ability to enter into agreements with viable new tenants for vacant space or for properties that the company takes back from financially troubled tenants, if any; its ability to make distributions to stockholders; its policies and plans regarding investments, financings and other matters; its tax status as a real estate investment trust; its ability to appropriately balance the use of debt and equity; its ability to access capital markets or other sources of funds; its critical accounting policies; and its ability to meet its earnings guidance. When the company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. The company’s expected results may not be achieved, and actual results may differ materially from expectations. This may be a result of various factors, including, but not limited to: the status of the economy; the status of capital markets, including availability and cost of capital; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies, responding to government investigations and punitive settlements and; operators’/tenants’ difficulty in cost-effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care and senior housing industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; the company’s ability to transition or sell facilities with profitable results; the failure to make new investments as and when anticipated; acts of God affecting the company’s properties; the company’s ability to re-lease space at similar rates as vacancies occur; the company’s ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant bankruptcies or insolvencies; government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements; liability or contract claims by or against operators/tenants; unanticipated difficulties and/or expenditures relating to future acquisitions; environmental laws affecting the company’s properties; changes in rules or practices governing the company’s financial reporting; and legal and operational matters, including real estate investment trust qualification and key management personnel recruitment and retention. Finally, the company assumes no obligation to update or revise any forward-looking statements or to update the reasons why actual results could differ from those projected in any forward-looking statements.

HEALTH CARE REIT, INC.

Financial Supplement

CONSOLIDATED BALANCE SHEETS (unaudited)
       
(In thousands)
  December 31,
    2008       2007  
Assets      
Real estate investments:      
Real property owned      
Land and land improvements $ 504,907     $ 447,029  
Buildings and improvements   4,653,871       4,224,955  
Acquired lease intangibles   133,324       131,312  
Real property held for sale, net of accumulated depreciation   48,054       0  
Construction in progress   639,419       313,709  
    5,979,575       5,117,005  
Less accumulated depreciation and intangible amortization   (600,781 )     (478,373 )
Total real property owned   5,378,794       4,638,632  
Loans receivable   482,885       381,394  
Less allowance for losses on loans receivable   (7,500 )     (7,406 )
    475,385       373,988  
Net real estate investments   5,854,179       5,012,620  
       
Other assets:      
Equity investments   1,030       1,408  
Deferred loan expenses   23,579       30,499  
Cash and cash equivalents   23,370       30,269  
Restricted cash   154,070       17,575  
Receivables and other assets   136,890       121,485  
    338,939       201,236  
       
Total assets $ 6,193,118     $ 5,213,856  
       
Liabilities and stockholders’ equity      
Liabilities:      
Borrowings under unsecured lines of credit arrangements $ 570,000     $ 307,000  
Senior unsecured notes   1,847,247       1,890,192  
Secured debt   446,525       507,476  
Accrued expenses and other liabilities   107,157       95,145  
Total liabilities   2,970,929       2,799,813  
       
Minority interests   10,603       9,687  
       
Stockholders’ equity:      
Preferred stock   289,929       330,243  
Common stock   104,635       85,412  
Capital in excess of par value   3,180,628       2,370,037  
Treasury stock   (5,145 )     (3,952 )
Cumulative net income   1,362,366       1,074,255  
Cumulative dividends   (1,723,819 )     (1,446,959 )
Accumulated other comprehensive income   (1,113 )     (7,381 )
Other equity   4,105       2,701  
Total stockholders’ equity   3,211,586       2,404,356  
       
Total liabilities and stockholders’ equity $ 6,193,118     $ 5,213,856  
               
CONSOLIDATED STATEMENTS OF INCOME (unaudited)
               
(In thousands, except per share data)
               
  Three Months Ended   Twelve Months Ended
  December 31,   December 31,
  2008     2007     2008     2007  
Revenues:              
Rental income $ 131,372     $ 111,036     $ 500,630     $ 417,673  
Interest income   10,886       8,151       40,063       25,823  
Other income   4,865       6,099       10,521       10,035  
Gross revenues   147,123       125,286       551,214       453,531  
               
Expenses:              
Interest expense   30,426       35,340       130,813       131,893  
Property operating expenses   11,389       10,286       43,990       34,707  
Depreciation and amortization   41,500       36,774       156,154       135,224  
General and administrative expenses   13,500       9,080       47,193       37,465  
Realized loss on derivatives   21,880       0       23,393       0  
Gain on extinguishment of debt   0       (1,081 )     (2,094 )     (1,081 )
Provision for loan losses   94       0       94       0  
Total expenses   118,789       90,399       399,543       338,208  
               
Income from continuing operations before income
 taxes and minority interests
  28,334       34,887       151,671       115,323  
               
Income tax expense   (136 )     (269 )     (1,306 )     (188 )
Income from continuing operations before minority interests   28,198       34,618       150,365       115,135  
               
Minority interests   2       169       (126 )     (238 )
Income from continuing operations   28,200       34,787       150,239       114,897  
               
Discontinued operations:              
Gain on sales of properties   33,120       11,662       163,933       14,437  
Impairment of assets   (32,648 )     0       (32,648 )     0  
Income from discontinued operations, net   (78 )     2,498       6,587       12,068  
    394       14,160       137,872       26,505  
Net income   28,594       48,947       288,111       141,402  
Preferred dividends   5,541       6,179       23,201       25,130  
Net income available to common stockholders $ 23,053     $ 42,768     $ 264,910     $ 116,272  
               
Average number of common shares outstanding:              
Basic   103,329       82,346       93,732       78,861  
Diluted   103,840       82,784       94,309       79,409  
               
Net income available to common stockholders per share:              
Basic $ 0.22     $ 0.52     $ 2.83     $ 1.47  
Diluted   0.22       0.52       2.81       1.46  
               
Common dividends per share $ 0.68     $ 0.66     $ 2.70     $ 2.2791  
                               
Funds From Operations Reconciliation
(Amounts in 000's except per share data)
    Three Months Ended   Twelve Months Ended
    December 31,   December 31,
    2008   2007   2008   2007
                 
Net income available to common stockholders   $ 23,053     $ 42,768     $ 264,910     $ 116,272  
Depreciation and amortization (1)     42,150       40,081       163,045       149,626  
Gain on sales of properties     (33,120 )     (11,662 )     (163,933 )     (14,437 )
Minority interests     (81 )     (88 )     (342 )     (344 )
Funds from operations     32,002       71,099       263,680       251,117  
Impairment of assets     32,648       0       32,648       0  
Realized loss on derivatives     21,880       0       23,393       0  
Terminated transaction costs     2,291       0       2,291       0  
One-time acquisition finder's fees     0       0       0       1,750  
Gain on extinguishment of debt     0       (1,081 )     (2,094 )     (1,081 )
Provision for loan losses     94       0       94       0  
Additional other income     (2,500 )     (3,900 )     (2,500 )     (3,900 )
Non-recurring income tax expense     0       0       1,325       0  
Funds from operations - normalized   $ 86,415     $ 66,118     $ 318,837     $ 247,886  
                 
Average common shares outstanding:                
Basic     103,329       82,346       93,732       78,861  
Diluted     103,840       82,784       94,309       79,409  
                 
Per share data:                
Net income available to common
 stockholders
               
Basic   $ 0.22     $ 0.52     $ 2.83     $ 1.47  
Diluted     0.22       0.52       2.81       1.46  
                 
Funds from operations                
Basic   $ 0.31     $ 0.86     $ 2.81     $ 3.18  
Diluted     0.31       0.86       2.80       3.16  
                 
Funds from operations - normalized                
Basic   $ 0.84     $ 0.80     $ 3.40     $ 3.14  
Diluted     0.83       0.80       3.38       3.12  
                 
FFO Payout Ratio                
Dividends per common share (2)   $ 0.68     $ 0.66     $ 2.70     $ 2.62  
FFO per diluted share   $ 0.31     $ 0.86     $ 2.80     $ 3.16  
FFO payout ratio     219 %     77 %     96 %     83 %
                 
FFO Payout Ratio - Normalized                
Dividends per share (2)   $ 0.68     $ 0.66     $ 2.70     $ 2.62  
FFO per diluted share - normalized   $ 0.83     $ 0.80     $ 3.38     $ 3.12  
FFO payout ratio - normalized     82 %     83 %     80 %     84 %
Notes:   (1)   Depreciation and amortization includes depreciation and amortization from discontinued operations.
    (2)   The $0.3409 prorated dividend paid on December 28, 2006 in connection with the Windrose merger has been included in the twelve months ended December 31, 2007.
           
Funds Available For Distribution Reconciliation
(Amounts in 000's except per share data)
  Three Months Ended   Twelve Months Ended
  December 31,   December 31,
  2008   2007   2008   2007
               
Net income available to common stockholders $ 23,053     $ 42,768     $ 264,910     $ 116,272  
Depreciation and amortization (1)   42,150       40,081       163,045       149,626  
Gain on sales of properties   (33,120 )     (11,662 )     (163,933 )     (14,437 )
Minority interests   (18 )     (8 )     (44 )     (10 )
Gross straight-line rental income   (4,682 )     (4,365 )     (20,489 )     (17,029 )
Prepaid/straight-line rent receipts   12,602       6,678       28,282       17,469  
Amortization related to above/(below) market leases, net   (363 )     (136 )     (1,039 )     (792 )
Non-cash interest expense   1,696       1,790       6,419       5,366  
Cap-ex, tenant improvements, lease commissions   (2,865 )     (1,763 )     (6,347 )     (4,292 )
Funds available for distribution   38,453       73,383       270,804       252,173  
Impairment of assets   32,648       0       32,648       0  
Realized loss on derivatives   21,880       0       23,393       0  
Terminated transaction costs   2,291       0       2,291       0  
One-time acquisition finder's fees   0       0       0       1,750  
Gain on extinguishment of debt   0       (1,081 )     (2,094 )     (1,081 )
Provision for loan losses   94       0       94       0  
Additional other income   (2,500 )     (3,900 )     (2,500 )     (3,900 )
Non-recurring income tax expense   0       0       1,325       0  
Prepaid/straight-line rent receipts   (12,602 )     (6,678 )     (28,282 )     (17,469 )
Funds available for distribution - normalized $ 80,264     $ 61,724     $ 297,679     $ 231,473  
               
Average common shares outstanding:              
Basic   103,329       82,346       93,732       78,861  
Diluted   103,840       82,784       94,309       79,409  
               
Per share data:              
Net income available to common stockholders              
Basic $ 0.22     $ 0.52     $ 2.83     $ 1.47  
Diluted   0.22       0.52       2.81       1.46  
               
Funds available for distribution              
Basic $ 0.37     $ 0.89     $ 2.89     $ 3.20  
Diluted   0.37       0.89       2.87       3.18  
               
Funds available for distribution - normalized              
Basic $ 0.78     $ 0.75     $ 3.18     $ 2.94  
Diluted   0.77       0.75       3.16       2.91  
               
FAD Payout Ratio              
Dividends per common share (2) $ 0.68     $ 0.66     $ 2.70     $ 2.62  
FAD per diluted share $ 0.37     $ 0.89     $ 2.87     $ 3.18  
FAD payout ratio   184 %     74 %     94 %     82 %
               
FAD Payout Ratio - Normalized              
Dividends per common share (2) $ 0.68     $ 0.66     $ 2.70     $ 2.62  
FAD per diluted share - normalized $ 0.77     $ 0.75     $ 3.16     $ 2.91  
FAD payout ratio - normalized   88 %     88 %     85 %     90 %
Notes:   (1)   Depreciation and amortization includes depreciation and amortization from discontinued operations.
    (2)   The $0.3409 prorated dividend paid on December 28, 2006 in connection with the Windrose merger has been included in the twelve months ended December 31, 2007.
         
Outlook Reconciliations
(Amounts in 000's except per share data)        
    Current Outlook
    Year Ended
    December 31, 2009
    Low   High
         
FFO Reconciliation:        
Net income available to common stockholders   $ 175,691     $ 186,741  
Depreciation and amortization (1)     174,000       174,000  
Funds from operations     349,691       360,741  
Non-recurring G&A expenses (2)     3,909       3,909  
Funds from operations - normalized   $ 353,600     $ 364,650  
         
Per share data (diluted):        
Net income available to common stockholders   $ 1.59     $ 1.69  
Funds from operations     3.16       3.26  
Funds from operations - normalized     3.20       3.30  
         
FAD Reconciliation:        
Net income available to common stockholders   $ 175,691     $ 186,741  
Depreciation and amortization (1)     174,000       174,000  
Gross straight-line rental income     (13,800 )     (13,800 )
Amortization related to above/(below) market leases, net     (1,300 )     (1,300 )
Non-cash interest expense     11,500       11,500  
Cap-ex, tenant improvements, lease commissions     (10,000 )     (10,000 )
Funds available for distribution     336,091       347,141  
Non-recurring G&A expenses (2)     3,909       3,909  
Funds available for distribution - normalized   $ 340,000     $ 351,050  
         
Per share data (diluted):        
Net income available to common stockholders   $ 1.59     $ 1.69  
Funds available for distribution     3.04       3.14  
Funds available for distribution - normalized     3.08       3.18  
Notes:   (1)   Depreciation and amortization includes depreciation and amortization from discontinued operations.
    (2)   Expenses to be recognized in connection with the departure of Raymond Braun.
         

Source: Health Care REIT, Inc.

Health Care REIT, Inc.
Scott Estes, 419-247-2800
Mike Crabtree, 419-247-2800